CareWare light 'patch' therapy for the treatment of acne vulgaris
In response to the COVID pandemic, Scripps Health has temporarily suspended enrollment for all clinical trials. Exceptions will exist for trials with curative intent, life-saving treatment or when no standard of care exists. For questions, please call Scripps Office for the Protection of Research Subjects at 858-678-6402.
E. Victor Ross, M.D.
This study is evaluating the effectiveness of combined blue and red light therapy as an “at home” treatment for moderate acne using wearable CareWare light patches. Study duration is about 6 weeks. Visits may be done in the clinic or by virtual/video visit.
Be 18 – 35 years of age
Have a clinical diagnosis of moderate acne vulgaris
Have at least 20 inflammatory lesions
Be willing to avoid excess sun exposure and not use topical or oral anti-acne medications including medicated shampoo or soap during the study period
Meet all other eligibility criteria
Have used oral retinoid therapy such as isotretinoin within the past 12 months
Have a diagnosis of psoriasis, seborrheic dermatitis or papulopustular rosacea
Have a history of keloids
Have an active infection
Have tattoos or excess scarring in the treatment areas
Be pregnant or planning to become pregnant, lactating, or nursing
CareWear light patches are wearable “stick and go” patches that are reusable and flexible. The patch uses patented LED light technology connected to a waterproof, rechargeable wireless controller that delivers a pre-programmed dosage of light.